Literature DB >> 20884364

Effect of biological matrix and sample preparation on qPCR quantitation of siRNA drugs in animal tissues.

Jessica Seitzer1, Hangchun Zhang, Martin Koser, Yi Pei, Marc Abrams.   

Abstract

INTRODUCTION: Quantitative pharmacokinetic measurement of short nucleotide sequences in animal tissues is critical to the successful development of siRNA-based drugs. Stem-loop qRT-PCR is a sensitive and precise methodology, but the effect of biological matrix and purity of the input sample has yet to be investigated.
RESULTS: The impact of lipid encapsulation, siRNA chemical modification and purity of the biological matrix on the stem-loop qRT-PCR assay was investigated. A comparison of siRNA standard curves in mouse liver homogenates before and after isolation of total RNA uncovered the potential for erroneous measurement due to significant loss of siRNA on purification columns. Recovery of chemically stabilized siRNA was improved by omission of the DNAse I digestion during RNA isolation. The stem-loop qRT-PCR method demonstrated excellent sensitivity and efficiency in mouse liver homogenates, plasma and whole blood. An optimized protocol based on these findings was used to quantitate siRNA in tissues after dosing mice with two different lipid nanoparticle formulations containing siRNA payloads.
CONCLUSIONS: Assay of crude homogenates, whole blood or plasma is more accurate, less resource intensive and more amenable to clinical translation than measurement of column-purified total RNA.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20884364     DOI: 10.1016/j.vascn.2010.09.005

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  5 in total

Review 1.  RNA interference and cancer therapy.

Authors:  Zhaohui Wang; Donald D Rao; Neil Senzer; John Nemunaitis
Journal:  Pharm Res       Date:  2011-10-19       Impact factor: 4.200

Review 2.  Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.

Authors:  Bin Shi; Marc Abrams
Journal:  J Histochem Cytochem       Date:  2013-03-14       Impact factor: 2.479

3.  Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery.

Authors:  Bin Shi; Ed Keough; Andrea Matter; Karen Leander; Stephanie Young; Ed Carlini; Alan B Sachs; Weikang Tao; Marc Abrams; Bonnie Howell; Laura Sepp-Lorenzino
Journal:  J Histochem Cytochem       Date:  2011-08       Impact factor: 2.479

4.  Evidence Supporting the Safety of Pegylated Diethylaminoethyl-Chitosan Polymer as a Nanovector for Gene Therapy Applications.

Authors:  Elsa Patricia Rondon; Houda Abir Benabdoun; Francis Vallières; Maicon Segalla Petrônio; Marcio José Tiera; Mohamed Benderdour; Julio Cesar Fernandes
Journal:  Int J Nanomedicine       Date:  2020-08-20

5.  Intratracheal Administration of siRNA Triggers mRNA Silencing in the Lung to Modulate T Cell Immune Response and Lung Inflammation.

Authors:  Bruce Ng; Tanesha Cash-Mason; Yi Wang; Jessica Seitzer; Julja Burchard; Duncan Brown; Vadim Dudkin; Joseph Davide; Vasant Jadhav; Laura Sepp-Lorenzino; Pedro J Cejas
Journal:  Mol Ther Nucleic Acids       Date:  2019-02-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.